|
Class 3 Device Recall ImmunoCAP Allergen Ri206 |
|
Date Initiated by Firm |
January 03, 2012 |
Date Posted |
February 17, 2012 |
Recall Status1 |
Terminated 3 on February 04, 2013 |
Recall Number |
Z-1055-2012 |
Recall Event ID |
60513 |
Product Classification |
Reagent, specific, analyte - Product Code MVU
|
Product |
ImmunoCAP Allergen Ri206, Cockroach American, Periplaneta americana
It is an analyte specific reagent and no intended use, however, it is typically used in vitro quantitive assay for the measurement of cockroach allergen IgE in human serum or plasma. |
Code Information |
Article number 14-5274-10, Lot number BDZ0P |
Recalling Firm/ Manufacturer |
Phadia US Inc 4169 Commercial Ave Portage MI 49002-9701
|
For Additional Information Contact |
Martin R. Mann 269-492-1957
|
Manufacturer Reason for Recall |
The firm found this lot of ImmunoCAP Allergen Ri206, American Cockroach does not contain sufficient levels of some cockroach allergens e.g. tropomyosin. Approximately 2% of the positive samples have a risk to fall below the Limit of Quantization (o .1 kUA/L).
|
FDA Determined Cause 2 |
Release of Material/Component prior to receiving test results |
Action |
ThermoFisher sent an URGENT RECALL NOTIFICATION letter dated December 22, 2011, to all affected consignees. The letter identifed the product, the problem, and the action to be taken by the conignee. Consignees were recommended to cease testing on the affected lot of product and, if so desired, substitute with ImmunoCAP Allergen i6, German Cockroach, until ImmunoCAP Allergen Ri206 was in stock. For any questions regarding this notification, contact Technical Support at 800.346.4364, option 2. |
Quantity in Commerce |
780; all sent to US, with 10 assays per sleeve |
Distribution |
Nationwide to include: MN, VA, NC, MO, SC, TX, MA, MI, FL, IL, PA, MD, UT, CO, GA, CA, |
Total Product Life Cycle |
TPLC Device Report
|
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
|
|
|